iSelect Fund Management

Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

Kultevat, Inc. is a biotechnology company focused on the cultivation and processing of dandelion varieties to produce natural rubber. The company primarily works with TKS Dandelion, a domestic source of rubber in the United States, Canada, and Europe, and also extracts rubber from Russian Dandelion. Kultevat's offerings include latex and bulk rubber products used in a variety of applications such as gloves, medical devices, and automotive parts, as well as renewable food co-products and sugar feedstocks for biofuel production. Founded in 2013 and based in Portageville, Missouri, Kultevat aims to provide sustainable alternatives to synthetic rubber, contributing positively to agricultural markets and reducing environmental impact.

Epharmix is a digital healthcare company that creates clinically validated and condition-specific communication tools. It helps care teams automatically monitor underserved patients to improve care & reduce workload with interventions proven to impact engagement and outcomes. It was founded in 2015 and headquartered in St Louis, Missouri.

Euclises Pharmaceuticals, Inc. is engaged in the research, development, and commercialization of innovative medicines targeting inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company focuses on creating novel pain and cancer medications that promise enhanced safety profiles compared to current therapies. The firm is built on pioneering inventions by Dr. John Talley, a renowned medicinal chemist known for developing Celebrex among other approved drugs. Euclises aims to introduce new compounds that provide improved efficacy and safety, positioning itself as a leader in the pharmaceutical industry. The company operates from the BioGenerator Accelerator Labs, where it continues to advance its research initiatives.

BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

Ward Alternative Energy was born from a passion to provide American, low cost, clean transportation fuels for vehicles. Discovering, producing and compressing natural gas in the field is a deep upstream expertise built over the past 50 years at Ward Petroleum. At Ward Alternative Energy, we add the down-stream natural gas, fueling and NGV expertise of our industry veterans. Our team is well prepared to be the natural gas fuels, station services and vehicle services provider and partner of choice for fleets. We started our business in Colorado in 2012 but are now expanding to Wyoming, New Mexico, northwest Texas and east through Kansas to St. Louis.

BenchmarkONE develops sales and marketing automation software tailored for small and mid-sized businesses. The company offers an integrated platform that includes customer relationship management (CRM) tools and sales automation features, allowing users to monitor contacts' activities, track deals, manage communications, and segment their audience. Additionally, BenchmarkONE provides email marketing capabilities with a user-friendly drag-and-drop email builder and marketing automation tools designed to engage visitors, prioritize leads, and optimize campaign investments. Originally known as Hatchbuck, Inc., the company rebranded to BenchmarkONE in June 2020 and has been operational since 2010, with its headquarters in St. Louis, Missouri. As of September 2019, BenchmarkONE functions as a subsidiary of Benchmark Internet Group, LLC.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and located in Columbia, Missouri, the company has created a proprietary drug product designed to function as a minimally invasive therapeutic cancer vaccine. This product is administered through intratumoral injection following tumor ablation, leveraging tumor-associated neoantigens to stimulate a systemic anti-tumor immune response. By transforming the process of tumor ablation into a therapeutic approach, ImmunoPhotonics aims to enhance treatment options for patients with late-stage metastatic cancers. The company has also established a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its mission in cancer treatment.

Kultevat, Inc. is a biotechnology company focused on the cultivation and processing of dandelion varieties to produce natural rubber. The company primarily works with TKS Dandelion, a domestic source of rubber in the United States, Canada, and Europe, and also extracts rubber from Russian Dandelion. Kultevat's offerings include latex and bulk rubber products used in a variety of applications such as gloves, medical devices, and automotive parts, as well as renewable food co-products and sugar feedstocks for biofuel production. Founded in 2013 and based in Portageville, Missouri, Kultevat aims to provide sustainable alternatives to synthetic rubber, contributing positively to agricultural markets and reducing environmental impact.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and located in Columbia, Missouri, the company has created a proprietary drug product designed to function as a minimally invasive therapeutic cancer vaccine. This product is administered through intratumoral injection following tumor ablation, leveraging tumor-associated neoantigens to stimulate a systemic anti-tumor immune response. By transforming the process of tumor ablation into a therapeutic approach, ImmunoPhotonics aims to enhance treatment options for patients with late-stage metastatic cancers. The company has also established a strategic partnership with Veterinary Cancer Therapeutics, LLC to further its mission in cancer treatment.

CrazyForEducation LLC is an educational technology company based in St. Louis, Missouri, founded in 2012 by Dr. Renato Cataldo. The company specializes in developing online teaching software and educational tools tailored for K-12 schools, teachers, students, and professionals. Its platform supports flip teaching by providing professional development resources, including recorded webinars and feedback videos for educators and students. Key features of the platform include tools for lesson assignments, digital note-taking, course management, and student organization. Additionally, CrazyForEducation offers uTutor.me, which allows users to access video lessons from K-12 and college educators, and ClinPharmEd, an online educational system for clinical pharmacists and pharmacy students. The company's mission is to enhance the educational experience through adaptive teaching models and comprehensive support for schools and districts.

AdFreeq is a socially integrated classified ad service that brings buyers and sellers together in real-time. The platform allows companies to present all of their goods or services as a simple ad on any website. AdFreeq was founded in 2011 and is based in Columbia, Missouri, United States.

Tansna Therapeutics, Inc. is a drug discovery and development company based in St. Louis, Missouri, founded in 2010. The company specializes in creating and commercializing oral drugs aimed at treating epilepsy and other central nervous system disorders. Its primary focus is on developing novel oral anticonvulsant agents designed to effectively reduce seizure frequency in patients with epilepsy. By providing safe and innovative treatment options, Tansna Therapeutics aims to enhance the quality of care for individuals suffering from these debilitating conditions.

Tansna Therapeutics, Inc. is a drug discovery and development company based in St. Louis, Missouri, founded in 2010. The company specializes in creating and commercializing oral drugs aimed at treating epilepsy and other central nervous system disorders. Its primary focus is on developing novel oral anticonvulsant agents designed to effectively reduce seizure frequency in patients with epilepsy. By providing safe and innovative treatment options, Tansna Therapeutics aims to enhance the quality of care for individuals suffering from these debilitating conditions.